Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft

Endocrinology

Volumn 140, Issue 5, 1999, Pages 2372-2381

  Gregory, Christopher W ^a   Kim, Desok ^a   Ye, Ping ^a   D'Ercole, A Joseph ^a   Pretlow, Thomas G ^b,c   Mohler, James L ^a,b   French, Frank S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CASTRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HORMONAL REGULATION; HORMONE SUBSTITUTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR XENOGRAFT;

EID: 0033306866     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.5.6702     Document Type: Article

References (49)

1. An adjustment to the 1997 estimate for new prostate cancer cases
2. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells
3. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia
4. The IGF axis in the prostate
5. Insulin-like growth factor system components in human prostate cancer cell lines: LNCaP, DU145, PC-3
6. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1
7. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo
8. Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: Characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog
9. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
10. Insulin-like growth factor binding proteins and their role in controlling IGF actions
11. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action
12. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
13. Human androgen receptor expression in prostate cancer following androgen ablation
14. Androgen receptor status of lymph node metastases from prostate cancer
15. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer
16. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
17. CWR22: Androgen-dependent xenograft model de-rived from a primary human prostatic carcinoma
18. Apoptosis in an androgen-dependent xenograft model derived from a primary human prostatic carcinoma
19. CWR22: The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar
20. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
21. Isolation of biologically active RNA from sources enriched in ribonucleases
22. In vivo actions of insulin-like growth factor-1 (IGF-I) on brain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice
23. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human
24. Organization, expression, and chromosomal location of the mouse insulin-like growth factor binding protein 5 gene
25. Gene expression of insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation
26. Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate
27. Quantitative immunohistochemistry using an image analyzer I. Hardware evaluation, image processing, and data analysis
28. A threshold selection method from gray-level histograms
29. Insulin-like growth factor binding proteins (IGFBP)-4, -5 and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization
30. Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer
31. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-1
32. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin
33. Synthesis and regulation of insulin-like growth factor binding protein-5 in FRTL-5 cells
34. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: Synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells
35. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion
36. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1α in ovine articular chondrocytes
37. Expression, effects, and fate of IGFBP-5 are different in normal and malignant osteoblast cells
38. 1α, 25-Dihydroxyvitamin D3 increases IGF binding protein-5 expression in cultured osteoblasts
39. Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-β and retinoic acid in the human prostate adenocarcinoma cell line PC-3
40. Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5
41. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression
42. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
43. Activation of the human androgen receptor through a protein kinase A signaling pathway
44. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
45. Effects of mitogens on androgen receptor-mediated transactivation
46. Expression and androgenic regulation of human prostate-specific kallikreins